Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-24-012070

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barrage Khalil Director 2024-03-25 Grant or award · PTIX Common stock Options +22,500 $1.74 $39,150 22,500 D: show line 1 in the form
Loading xslF345X05/ownership.xml…